Zhejiang Kangmu Pharmaceutical Co., Ltd. (Group) was founded in January, 2003. It is located in Chengbei Industrial Park (at 358# of Luohuan Road) of Shengzhou City in Zhejiang Province, covering an area of 93.55 mu. Plant construction area is 32,000 square meters. Total assets are more than 300 million Yuan. Nowadays there are over 200 employees. The company is a modern manufacturing enterprise of florfenicol, tilmicosin series bulk pharmaceutical materials approved by National Agricultural Department. And it has gained production licence and registered number of approval. The company is a national new and high-tech enterprise integrated of scientific research, production, operation and investment, with self-export rights.

The company has established Zhejiang Provincial agricultural technical research and development center, and Shaoxing enterprise technology center. Its research and development capacity is at domestic leading level relying on technology innovation. It is professional in research and manufacturing of efficient, low-toxic and low residue veterinary used bulk materials, intermediates and preparations. It is engaged in human health, animal healthcare, ecological environment protection and green agriculture industry.

Florfenicol series bulk materials, leading product of the company, is Zhejiang new and high-tech product with provincial scientific and technological achievements. And it is listed in provincial key scientific project and state torch plan. 40% products are sold in Middle East, South America and Southeast Asia regions. The sales network has been spread all around the world. Annual value of production and the sale is over 400 million Yuan. The company earns foreign exchange through exports for 15 million dollars. The profit and tax exceeds 50 million Yuan. In 2017, more than 50 million Yuan would be put in environmental protection and technology innovation. There is excellent economic benefit and social benefit.